| Source HCPCS Code |
|
Target NDC Code |
J0850
|
⇄
|
44206-0532-11
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0850
INJECTION, CYTOMEGALOVIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN), PER VIAL
|
⇄
|
44206-3101-01
CYTOGAM (PF)
|
| Detail Information |
| Relationship Start Date |
2/20/2007 |
| Relationship End Date |
4/29/2011 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
NA |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0850
|
⇄
|
44206-3101-10
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0850
Injection, cytomegalovirus immune globulin intravenous (human), per vial
|
⇄
|
49591-0532-50
CYTOGAM 2.5 GM/50 ML VIAL
|
| Detail Information |
| Relationship Start Date |
10/11/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0850
Injection, cytomegalovirus immune globulin intravenous (human), per vial
|
⇄
|
49591-0532-51
CYTOGAM 2.5 GM/50 ML VIAL
|
| Detail Information |
| Relationship Start Date |
10/11/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0850
INJECTION, CYTOMEGALOVIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN), PER VIAL
|
⇄
|
60574-3101-01
CYTOGAM (S.D.V.,PF)
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
1/31/2007 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0850
Injection, cytomegalovirus immune globulin intravenous (human), per vial
|
⇄
|
70257-0532-50
CYTOGAM 2.5 GM/50 ML VIAL
|
| Detail Information |
| Relationship Start Date |
07/01/2022 |
| Relationship End Date |
01/10/2024 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0850
Injection, cytomegalovirus immune globulin intravenous (human), per vial
|
⇄
|
70257-0532-51
CYTOGAM 2.5 GM/50 ML VIAL
|
| Detail Information |
| Relationship Start Date |
04/27/2017 |
| Relationship End Date |
01/10/2024 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0850
Cytomegalovirus imm iv /vial
|
⇄
|
49591-0532-51
Cytogam
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|